Genie Therapeutics: Funding, Investors & Team (Sep 2026)
Genie Therapeutics was founded in 2007 by Dr. Tabor with the intention of developing gene therapy techniques to help patients in the process of rejuvenating and regenerating their skin. The company's main goal is to utilize gene transfer for healing purposes, aiming to restore and regenerate the skin. The focus of Genie Therapeutics revolves around their patented, third-generation non-viral gene therapy technologies, which are designed to deliver therapeutic treatments that can assist numerous patients in transforming and revitalizing their skin, ultimately regaining their youthful appearance. The team at Genie Therapeutics possesses a wealth of expertise in the field and is strongly committed to utilizing gene therapies in order to achieve significant enhancements in skin health.
Genie Therapeutics has raised $50k across 1 funding round on record, the most recent a Seed of $50k announced in Jul 2023.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Genie Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Genie Therapeutics Funding Rounds
Genie Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Genie Therapeutics Funding Compared to Other Health Care Startups
Genie Therapeutics' latest round of $50k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genie Therapeutics in Health Care and Wilmington
Companies Similar to Genie Therapeutics
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Genie Therapeutics Funding FAQs
What does Genie Therapeutics do?
Genie Therapeutics was founded in 2007 by Dr. Tabor with the intention of developing gene therapy techniques to help patients in the process of rejuvenating and regenerating their skin. The company's main goal is to utilize gene transfer for healing purposes, aiming to restore and regenerate the skin. The focus of Genie Therapeutics revolves around their patented, third-generation non-viral gene therapy technologies, which are designed to deliver therapeutic treatments that can assist numerous patients in transforming and revitalizing their skin, ultimately regaining their youthful appearance. The team at Genie Therapeutics possesses a wealth of expertise in the field and is strongly committed to utilizing gene therapies in order to achieve significant enhancements in skin health.
How much funding has Genie Therapeutics raised?
Genie Therapeutics has raised $50k across 1 round on record. The most recent is a Seed of $50k announced in Jul 2023.
When did Genie Therapeutics last raise funding?
Genie Therapeutics' most recent funding round on record is a Seed of $50k, announced in Jul 2023.
Who is the CEO of Genie Therapeutics?
Aaron Tabor is listed as CEO at Genie Therapeutics.
Where is Genie Therapeutics headquartered?
Genie Therapeutics is based in Wilmington, Delaware, United States.
How many employees does Genie Therapeutics have?
Genie Therapeutics is in the 1-10 employee band.
How does Genie Therapeutics' funding compare to other Health Care startups?
Genie Therapeutics' latest round of $50k is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Genie Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genie Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.